$21.820
-0.050 (-0.23%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
¿Debería comprar acciones de Braveheart Bio, Inc.?
Braveheart Bio, Inc. (BRVE) appears to be a good buy right now due to its recent price of $21.44, which is significantly below the analyst price targets ranging from $40 to $48. The stock has shown a strong 5-day change of +14.59%, indicating positive momentum. Additionally, the RSI is at 65.87, suggesting that while the stock is nearing overbought territory, it still has room for growth. The main risk is the substantial net loss reported for Q2 2026 of $18.60 million, which could impact future performance if not managed effectively.
BRVE cerró en $21.82 el Tuesday, tras bajar -0.23%
Braveheart Bio, Inc. (BRVE) last closed at $21.8199997, losing -0.23%. These facts feed the 1-day and 1-week BRVE price prediction above.
Factores de la previsión
Los factores de la previsión de Braveheart Bio, Inc. (BRVE) combinan patrones gráficos similares, estacionalidad y medias móviles.
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Análisis de estacionalidad de BRVE
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.